Clinical Trials on Androgen-insensitive Prostate Cancer
Total 5487 results
-
Bavarian NordicCompletedAndrogen-insensitive Prostate CancerUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Aragon Pharmaceuticals, Inc.Completed
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
The Netherlands Cancer InstituteAstellas Pharma IncCompletedProstate Cancer | Androgen Receptor Abnormal | DNA
-
University of UtahTerminatedStage IV Prostate Cancer | Metastatic Prostatic Adenocarcinoma | Castration-Sensitive Prostate Carcinoma | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterWake Forest University Health SciencesCompletedCastration-resistant Prostate Cancer | Androgen Deprivation TherapyUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
Institut Paoli-CalmettesTerminatedAndrogen-independent Prostate CancerFrance
-
Myovant Sciences GmbHRecruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Fudan UniversityNot yet recruitingMetastatic Prostate Cancer | Castration-Sensitive Prostate CancerChina
-
Azienda Ospedaliero-Universitaria CareggiNot yet recruitingOligometastatic Hormone Sensitive Prostate CancerItaly
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Dr. Patrick CheungWithdrawnHormone Sensitive Oligometastatic Prostate CancerCanada
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Spanish Oncology Genito-Urinary GroupBristol-Myers Squibb; Syntax for Science, S.LActive, not recruitingMetastatic Hormone-sensitive Prostate CancerSpain
-
Washington University School of MedicineBristol-Myers Squibb; The Foundation for Barnes-Jewish Hospital; Bavarian Nordic and other collaboratorsCompletedMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Peng Wang, MD PhDWithdrawnMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Alliance Foundation Trials, LLC.BayerRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate CancerUnited States
-
Toni Choueiri, MDWithdrawnAdenocarcinoma of the ProstateUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.Not yet recruitingProstate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate CancerUnited States
-
AstraZenecaCompletedGnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer PatientsKorea, Republic of
-
Institut Mutualiste MontsourisUniversity of Turin, ItalyRecruitingProstate Cancer | Androgen Deprivation TherapyFrance
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedProstate CancerUnited States
-
University of Wisconsin, MadisonMadison Vaccines IncorporatedCompletedProstate CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingChemotherapy Effect | Metastatic Prostate Cancer | Hormone Sensitive Prostate CancerChina
-
Azienda Unità Sanitaria Locale Reggio EmiliaUniversity of Modena and Reggio Emilia; Fondazione Manodori di Reggio EmiliaCompletedProstate Cancer | Radiotherapy | Androgen Deprivation TherapyItaly
-
University of FloridaDriverWithdrawn
-
Norwegian School of Sport SciencesKing's College London; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaboratorsTerminatedProstate Cancer | Resistance Exercise | Androgen Deprivation TherapyNorway
-
Universitaire Ziekenhuizen KU LeuvenUnknownProstate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen AntagonistsBelgium
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
National University Hospital, SingaporeNational University of SingaporeActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Hormone Sensitive Prostate CancerSingapore
-
Dana-Farber Cancer InstitutePfizer; Prostate Cancer FoundationRecruitingProstate Cancer | Prostate Cancer Metastatic | Androgen Deprivation TherapyUnited States
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI); Xencor, Inc.RecruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
University of ArkansasNot yet recruitingCastration Sensitive Prostate CancerUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingChemotherapy Effect | DNA Damage Repair Deficiency | Chemotherapeutic Toxicity | Hormone Sensitive Metastatic Prostate CancerChina
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHormone Sensitive Prostate CancerChina
-
Associacao de Investigacao de Cuidados de Suporte...Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.; University Institute... and other collaboratorsUnknownProstate Cancer | Androgen Deprivation TherapyPortugal
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
Royal Marsden NHS Foundation TrustJanssen, LPRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)United Kingdom